Slone Partners

About Us

With a dedicated focus on the life sciences and healthcare industries, Slone Partners is a premier executive search and talent advisory firm with more than 25 years of success delivering visionary leaders and fractional talent who build and scale amazing organizations. With a nationwide presence and global reach, we specialize in discovering and placing innovative leaders, including world-class Board, C-Suite, and upper management professionals.

 

ACHIEVEMENTS

Recent Placements

Slone Partners

Leadership

8

Our leadership is deeply embedded in the industry and supported by an Advisory Board of experts from every sector that we serve.

Staying at the cutting edge of every change in the market allows us to deliver the right candidates for your business and provide invaluable counsel no matter how unique your needs.

Slone Partners

Solutions And Expertise

Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for companies focused in biotechnology, pharma services, life science tools, diagnostics, genomics, clinical services, medical devices, data and analytics, and food sciences.

Solutions
  • Board/Director Search
  • Executive Recruitment
  • Executive Search
  • Fractional
  • Fractional and Interim Services
  • Fractional Executive
  • On-Demand Recruiting
  • On-Demand Talent Solutions
  • Professional Search
Industries
  • Biotechnology
  • Executive Search
  • Healthcare
  • Healthcare Services
  • Healthtech
  • Hospital Foundations
  • Life Sciences
  • Life Sci./Healthcare
  • Medical Devices
  • Pharmaceuticals
  • Science and Research
Functions
  • Board Members
  • Board of Directors
  • Business Leaders
  • C-Level
  • C-Level Leaders
  • C-Suite
  • Clinical Directors
  • Clinical Operations
  • Director/VP
  • General Counsel
  • Head of Department
  • Healthcare
  • Healthcare Board Placements
  • President
  • SVP
  • Vice President

Slone Partners

News Briefings

Despite Jobless Claims Dropping to New Low, Companies Still Having a Hard Time Finding Talent

The Labor Department reported that 281,000 Americans have filed new claims for state unemployment benefits, a decrease of 10,000. This is the lowest level for initial claims since March 14, 2020 when it was 256,000. The previous week’s level was revised up by 1,000 from 290,000 to 291,000. The four-week moving average was 299,250, a decrease

Slone Partners Recruits CFO for BillionToOne

Over the past few months, numerous healthcare and life sciences organizations have turned to executive search firms to find new leaders. In the era of COVID-19, the sector has been a burgeoning area for executive search firms to ply their trade. Recently, life sciences-focused search firm Slone Partners placed Nipun Soni as the new chief financial officer

Slone Partners Recruits Chief Legal Officer for InterVenn Biosciences

Over the past few months, numerous healthcare and life sciences organizations have turned to executive search firms to find new leaders. In the era of COVID-19, the sector has been a burgeoning area for executive search firms to ply their trade. Recently, life sciences-focused search firm Slone Partners placed Stephana Patton as chief legal officer at InterVenn Biosciences. “Dr. Patton

Executive Recruiters Get Back to Business

Executive recruiters spent the better part of last year resetting expectations – the result of an unprecedented, and completely unexpected, interruption to their business due to COVID-19. But according to search professionals across the spectrum, that disruption has now receded, and business is returning to levels not seen since the waning days of 2019 and

Slone Partners

Press Releases

Slone Partners Places Jonathan Birchall as Chief Commercial Officer at PhaseBio Pharmaceuticals

SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Jonathan Birchall as Chief Commercial Officer at PhaseBio Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases. Birchall has more than 25 years of

Slone Partners Places Nigel Beard Ph.D. as Chief Technology Officer at Encodia

(Nov. 2, 2021) Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Nigel Beard Ph.D. as Chief Technology Officer (CTO) at Encodia, a rapidly growing platform company that is developing a new generation of protein analysis tools based on single-molecule protein sequencing. Beard succeeds Kevin

Slone Partners Places Scott Gleason as Senior Vice President Investor Relations and Corporate Communications at OraSure Technologies

SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Scott Gleason as Senior Vice President Investor Relations and Corporate Communications at OraSure Technologies, a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services. Gleason possesses a range of corporate

Slone Partners Places Stephana Patton as Chief Legal Officer at InterVenn Biosciences

(May 19, 2021) Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Stephana Patton, Ph.D., J.D. as Chief Legal Officer (CLO) at InterVenn Biosciences. Patton brings more than 20 years of legal experience to InterVenn. She most recently served as General Counsel, Corporate Secretary, and

Slone Partners Places Sotirios Karathanasis as Chief Science Officer at Enveda Biosciences

(April 29, 2021) Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Sotirios Karathanasis, Ph.D. as the new Chief Science Officer (CSO) at Enveda Biosciences. In his new role, Dr. Karathanasis will lead the company’s small molecule drug discovery portfolio and work with Enveda’s preclinical